News

A genetic analysis hints at why COVID-19 can mess with smell

People with variants near smell-related genes may have a higher risk of losing smell or taste.
Erin Garcia de Jesús, Science News
By Erin Garcia de Jesús, Science News
Jan. 23, 2022

For many people, one of the fastest tip-offs that they have COVID-19 is the loss of taste or smell. Now researchers have pinpointed some genetic variants in people that may make it more likely that the coronavirus might rob them of these senses.

A study of nearly 70,000 adults with COVID-19 found that individuals with certain genetic tweaks on chromosome 4 were 11% more likely to lose the ability to smell or taste than people without the changes, researchers report January 17 in Nature Genetics. The data come from people who’d had their DNA analyzed by genetic testing company 23andMe and self-reported a case of COVID-19.

Two genes, UGT2A1 and UGT2A2, that help people smell reside in the region of chromosome 4 linked to sensory loss during infection, epidemiologist Janie Shelton of 23andMe and colleagues found. Both genes make enzymes that metabolize substances called odorants, which produce distinctive smells.

Studies suggest that loss of smell, a hallmark symptom of COVID-19, stems from infections taking hold in smell-supporting cells called sustentacular cells. It’s possible that the genetic variants near UGT2A1 and UGT2A2 could affect how the two genes are turned on or off to somehow mess with smell during an infection, Shelton says.

The team combined loss of smell and taste in one survey question so the study can’t parse whether the genetic variants are involved in the loss of one sense over the other. “When you lose your taste of smell, often your taste is highly diminished,” Shelton says. Taste can also go away without loss of smell.

Some people have a sustained loss of smell, even after the coronavirus leaves their bodies, Shelton says. Understanding how the virus snuffs out sniffing ability could help researchers find ways to bring it back.

This story was originally published by Science News, a nonprofit independent news organization.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Erin Garcia de Jesús, Science News
Erin Garcia de Jesús, Science News

Erin I. Garcia de Jesus is a staff writer at Science News. She holds a Ph.D. in microbiology from the University of Washington and a master’s in science communication from the University of California, Santa Cruz.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Journal News

Antibiotic sensor directly binds drug in resistant bacteria

Oct. 8, 2025

Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.